Form 4: Notable Labs Director Thomas Graney Reports Acquisition of 40,247 Ordinary Shares

Director Thomas Graney reports acquiring 40,247 ordinary shares of Notable Labs, Ltd. through a grant of restricted shares.

Summary

• On May 8, 2024, Thomas Graney, a director of Notable Labs, Ltd., acquired 40,247 ordinary shares.
• The shares were acquired through a grant of restricted shares at a price of $0.
• The restricted shares vest in two equal annual installments from the date of grant.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing indicating a transaction by a company insider. The acquisition of shares by a director is generally viewed as a positive sign, but without additional context, the impact is limited.

Positives

• The acquisition of shares by a director could be seen as a positive sign of confidence in the company's future.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• Shareholders may view the director's acquisition of shares as a positive signal.

Key Dates

Keywords

Notable Labs, Thomas Graney, Director, Ordinary Shares, Restricted Shares, Acquisition, Form 4, NTBL